A user is confused about a dermatologist's positive assessment of their scalp despite concerns abouttheir hairline. They discuss using oral minoxidil, concerns about side effects from finasteride, and difficulty finding topical finasteride.
The conversation is aboutthe lack of discussion on Low-level laser lighttherapy (LLLT) laser caps for hair loss. One user questions their effectiveness, and another asserts they don't work.
The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking itto dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.
Topical Finasteride doesn't directly reduce 5ar enzyme on scalp and has the same mechanism as oral, needing to go through the liver. Users debate the accuracy of this information and discuss various studies and experiences.
Hair loss discussion mentions HMI-115 efficacy in 3 months after Phase II study. Users discuss treatment effectiveness and mention massive regrowth in previously bald areas.
A Phase 1 update for the HMI 115 clinical trial, which involves 16 participants and is expected to end in July 2023; as well as changes to the recruitment process, including treatment protocols with Minoxidil, Finasteride, and RU58841.
A user visited a dermatologist for hair loss concerns and was prescribed a hair lotion called "Lotion revolotion evdermia," which is meant for hair toning, hydration, and anti-aging, not regrowth. The user found the dermatologist's behavior and the prescription to be questionable.
The progress of Phase I of HMI-115, a potential hair loss treatment, which consists of Minoxidil, finasteride, and RU58841. The estimated completion date is June.
This user has conducted data scraping of 365 Reddit posts on the hairloss drug Pyrilutamide over the last year to analyse efficacy and side effects. The findings, which are available in a 19 page report with graphs, suggestthat 22% of Pyrilutamide users experience positive results while 63% experience symptoms. A larger analytics project is proposed for other drugs with enough demand.
A user shared their experience with high cholesterol, glucose, and potential metabolic syndrome after using Finasteride and Dutasteride for hair loss. They plan to improve their health with diet and exercise before considering medication.
A 20-year-old male using Minoxidil and finasteride for 6 months and keto shampoo for 5 months saw initial improvement in dandruff, butthe condition returned. He recently started using 3% salicylic acid shampoo and seeks advice for persistent dandruff, which is oily and localized to the left side of his scalp.
KX-826 (Pyrilutamide) being tested in the US for hair loss treatment and thatthey have found enough people to participate in phase II clinical trials. Other treatments discussed are Minoxidil, finasteride, and RU58841.
Hair cloning is discussed, focusing on its current status and potential availability. Treatments mentioned include Minoxidil, finasteride, and RU58841.
A 37-year-old person taking 0.25mg of Finasteride daily to treat hair loss, with the goal of saving existing hair rather than regrowing it, who experienced an expected dramatic shed and subsequent improvement in their hair noticeably after 3 months. A 38 year old had a similar experience with the same timeline and result.
42-year-old used finasteride, minoxidil, dermapen, and nizoral for 12 months, achieving significant hair growth. Consistency and patience are important for success.
First patient dosed with Pyrilutamide (Kintor) Phase III for hair loss treatment. Pyrilutamide differs from approved treatments as it competes with DHTto bind hair follicles, potentially reducing side effects.
A user is experiencing severe hair loss, diagnosed with seborrheic dermatitis, and is using Ketoconazole and beclomethasone. They are concerned about potential female pattern baldness and are seeking reassurance and advice.
The conversation discusses the variability in effectiveness and safety of generic finasteride from different manufacturers, with some generics potentially containing impurities. Users shared their experiences with various brands, questioning if different brands affect hair loss treatment outcomes.
Follica's preferred microneedling protocol for hair growth, which includes needle depth, frequency and movement parameters as well as the use of topical treatments such as minoxidil and finasteride.
A 34 year old female with androgenic alopecia who has tried treatments such as Spironolactone, Desogen, Minoxidil and Finasteride in order to address her hair loss. It also details the experiences of other women taking Spironolactone for Female Pattern Hair Loss (FPHL).
RU58841 is used topically to prevent hair loss by blocking DHT, with suggestions to drink grapefruit juice, take breaks, avoid microneedling, and use lower concentrations to reduce side effects. Users discuss applying it at nightto minimize systemic absorption.
Using 2.5mg oral minoxidil and 1mg oral finasteride daily leads to significant hair regrowth without side effects, especially atthe crown. Consistency is crucial, and some users consider additional methods like derma rolling.
A father experienced hair regrowth in his 60s after taking dutasteride for prostate issues, prompting discussions about its effectiveness compared to finasteride for hair loss. Users shared personal experiences, with some preferring dutasteride due to perceived effectiveness and fewer side effects.
Skepticism about hair loss research motivations, suggesting financial interests hinder finding a cure. Mentions treatments like minoxidil, finasteride, and dutasteride, but notes they are not cures.
The user experienced hair loss and initially used Finasteride, but switched to Dutasteride after continued shedding. Dutasteride stabilized their hair density with mild side effects, and they did not use Minoxidil.
A user shared their significant hair regrowth progress using topical minoxidil, oral finasteride, and minoxidil chews, while transitioning to generic versions. They also mentioned using batana oil and microneedling, with no side effects reported.
The conversation discusses the challenges and experiences of using minoxidil, finasteride, and dutasteride for hair loss, focusing on the shedding phase and its impact on hair appearance. Users share their personal experiences, side effects, and hopes for improvement, with some considering or having undergone hair transplants.
The user experienced significant hair regrowth after 2.5 years of using Minoxidil 5% and hormone replacementtherapy (HRT) with Lupron, despite initial scalp irritation. Finasteride was ineffective for them.